One of the outpatient treatment options for people in Oak Park who are struggling with opioid dependence and addiction is opioid maintenance therapy. Some clinics and doctors are authorized to dispense specific medications to opioid dependent individuals, many of which are opioids themselves and are habit forming. In low doses however, the client doesn't experience high feelings and also doesn't experience intense cravings and isn't experiencing opioid withdrawal. Methadone is the first med tried for this sole purpose, but there are other choices currently to choose from.
Methadone is an opiate and can be taken at an outpatient medical center certified to administer the med, that is taken daily as a pill or liquid. The cost of the med is around $150 monthly. Buprenorphine is also an opiate based drug, and is a pill often taken one day on, one day off. But unlike Methadone that can only be given in highly well-regulated medical centers, Buprenorphine can be prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is about $300 /month for the generic of the med. There is also a version of buprenorphine that contains the ingredient naloxone, which is a drug that blocks the effects of opioids. A person consuming this formulation, also known as Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It too is taken daily, and is priced around $450 a month. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other drugs aforementioned it is an opioid blocker and isn't an opiate. A person has the choice to take this drug as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents someone from feeling high from opioids, and therefore lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 monthly.
There are 1 Alcohol and Drug Rehabilitation Facilities offering this service in Oak Park, IL
For All Drug and Alcohol Rehab Centers In Oak Park, Click Here.